Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PureTech Health plc (PRTC) Debt to Equity (2020 - 2023)

PureTech Health (PRTC) has disclosed Debt to Equity for 3 consecutive years, with $0.03 as the latest value for Q4 2022.

  • On a quarterly basis, Debt to Equity rose 11.5% to $0.03 in Q4 2022 year-over-year; TTM through Dec 2022 was $0.03, a 11.5% increase, with the full-year FY2022 number at $0.03, up 11.5% from a year prior.
  • Debt to Equity was $0.03 for Q4 2022 at PureTech Health, up from $0.03 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.03 in Q4 2022 to a low of $0.02 in Q4 2020.
  • A 3-year average of $0.03 and a median of $0.03 in 2021 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: increased 15.13% in 2021, then grew 11.5% in 2022.
  • PureTech Health's Debt to Equity stood at $0.02 in 2020, then rose by 15.13% to $0.03 in 2021, then grew by 11.5% to $0.03 in 2022.
  • Per Business Quant, the three most recent readings for PRTC's Debt to Equity are $0.03 (Q4 2022), $0.03 (Q4 2021), and $0.02 (Q4 2020).